Most Popular
-
1
Now is no time to add pressure on businesses: top executives
-
2
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
3
Seoul to host winter festival from Dec. 13
-
4
Blackpink's solo journeys: Complementary paths, not competition
-
5
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
6
Korean Air offers special flights for mileage users
-
7
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
8
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
9
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
10
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
[THE INVESTOR] Samsung BioLogics announced on Sept. 7 that it received six manufacturing licenses from the European Medicines Agency and the US Food and Drug Administration.
Samsung BioLogics is the world’s third largest biologics contract manufacturer by capacity.
With the latest licenses, Samsung BioLogics now has seven production licenses.
A contract manufacturer is required to obtain production licenses before operations can begin regardless of whether the product has been approved by the authorities.
By Choi He-suk (cheesuk@heraldcorp.com)
Samsung BioLogics is the world’s third largest biologics contract manufacturer by capacity.
With the latest licenses, Samsung BioLogics now has seven production licenses.
A contract manufacturer is required to obtain production licenses before operations can begin regardless of whether the product has been approved by the authorities.
By Choi He-suk (cheesuk@heraldcorp.com)
